Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chien-Fu Hung

Showing results (51-60 of 265) with videos related to

Pageof 27
Sort By:
Molecular Therapy : the Journal of the American Society of Gene Therapy|January 21, 2010
Enhancing the therapeutic effect against ovarian cancer through a combination of viral oncolysis and antigen-specific immunotherapyYu-Qian Zhang, Ya-Chea Tsai, Archana Monie, et al.
Vaccine|September 6, 2008
alpha-Galactosylceramide enhances the protective and therapeutic effects of tumor cell based vaccines for ovarian tumorsYoun Seok Choi, Talia Hoory, Archana Monie, et al.
Vaccine|June 15, 2010
Carrageenan as an adjuvant to enhance peptide-based vaccine potencyYu-Qian Zhang, Ya-Chea Tsai, Archana Monie, et al.
Cancer Research|October 19, 2007
Cancer immunotherapy using irradiated tumor cells secreting heat shock protein 70Chih-Long Chang, Ya-Chea Tsai, Liangmei He, et al.
Vaccine|June 2, 2009
Treatment with demethylating agent, 5-aza-2'-deoxycytidine enhances therapeutic HPV DNA vaccine potencyDan Lu, Talia Hoory, Archana Monie, et al.
The Laryngoscope|September 5, 2017
Prophylactic immunization with human papillomavirus vaccines induces oral immunity in miceJulie Ahn, Shiwen Peng, Chien-Fu Hung, et al.
Biomolecules|April 25, 2020
Sequential Interferon β-Cisplatin Treatment Enhances the Surface Exposure of Calreticulin in Cancer Cells via an Interferon Regulatory Factor 1-Dependent MannerPei-Ming Yang, Yao-Yu Hsieh, Jia-Ling Du, et al.
Journal of Virology|February 28, 2002
Improving DNA vaccine potency by linking Marek's disease virus type 1 VP22 to an antigenChien-Fu Hung, Liangmei He, Jeremy Juang, et al.
Journal of Biomedical Science|October 12, 2022
Identification of human MHC-I HPV18 E6/E7-specific CD8 + T cell epitopes and generation of an HPV18 E6/E7-expressing adenosquamous carcinoma in HLA-A2 transgenic miceShiwen Peng, Deyin Xing, Louise Ferrall, et al.
Vaccine|December 6, 2008
Enhancing therapeutic HPV DNA vaccine potency through depletion of CD4+CD25+ T regulatory cellsChi-Mu Chuang, Talia Hoory, Archana Monie, et al.
Pageof 27

Showing results (51-60 of 265) with videos related to

Sort By:
Pageof 27
Molecular Therapy : the Journal of the American Society of Gene Therapy|January 21, 2010
Enhancing the therapeutic effect against ovarian cancer through a combination of viral oncolysis and antigen-specific immunotherapyYu-Qian Zhang, Ya-Chea Tsai, Archana Monie, et al.
Vaccine|September 6, 2008
alpha-Galactosylceramide enhances the protective and therapeutic effects of tumor cell based vaccines for ovarian tumorsYoun Seok Choi, Talia Hoory, Archana Monie, et al.
Vaccine|June 15, 2010
Carrageenan as an adjuvant to enhance peptide-based vaccine potencyYu-Qian Zhang, Ya-Chea Tsai, Archana Monie, et al.
Cancer Research|October 19, 2007
Cancer immunotherapy using irradiated tumor cells secreting heat shock protein 70Chih-Long Chang, Ya-Chea Tsai, Liangmei He, et al.
Vaccine|June 2, 2009
Treatment with demethylating agent, 5-aza-2'-deoxycytidine enhances therapeutic HPV DNA vaccine potencyDan Lu, Talia Hoory, Archana Monie, et al.
The Laryngoscope|September 5, 2017
Prophylactic immunization with human papillomavirus vaccines induces oral immunity in miceJulie Ahn, Shiwen Peng, Chien-Fu Hung, et al.
Biomolecules|April 25, 2020
Sequential Interferon β-Cisplatin Treatment Enhances the Surface Exposure of Calreticulin in Cancer Cells via an Interferon Regulatory Factor 1-Dependent MannerPei-Ming Yang, Yao-Yu Hsieh, Jia-Ling Du, et al.
Journal of Virology|February 28, 2002
Improving DNA vaccine potency by linking Marek's disease virus type 1 VP22 to an antigenChien-Fu Hung, Liangmei He, Jeremy Juang, et al.
Journal of Biomedical Science|October 12, 2022
Identification of human MHC-I HPV18 E6/E7-specific CD8 + T cell epitopes and generation of an HPV18 E6/E7-expressing adenosquamous carcinoma in HLA-A2 transgenic miceShiwen Peng, Deyin Xing, Louise Ferrall, et al.
Vaccine|December 6, 2008
Enhancing therapeutic HPV DNA vaccine potency through depletion of CD4+CD25+ T regulatory cellsChi-Mu Chuang, Talia Hoory, Archana Monie, et al.
Pageof 27